§ BIOTECHNOLOGY
USD · Biotechnology

KRYS

KRYSTAL BIOTECH INC
USDSector · BiotechnologyBeta · 0.55
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
284 increased/new, 113 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/E37.2P/B5.86
EPS (TTM)6.84
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Fidelity Management4.4M0.1%+1%
BlackRock, Inc.3.9M0.0%+0%
Avoro Capital Advisors LLC2.9M7.3%n/a
VANGUARD PORTFOLIO MANAGEMENT LLC1.5Mn/an/a
State Street1.3M0.0%−2%
VANGUARD CAPITAL MANAGEMENT LLC1.2Mn/an/a
◇ AC INTELLIGENCE

Top institutional owners for KRYS as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER46.9% · 259 holders
QUALITY / COMPOUNDER25.8% · 28 holders
PASSIVE / INDEX19.1% · 11 holders
DEALER / BANK10.1% · 31 holders
INCOME / DEFENSIVE1.8% · 26 holders
SYSTEMATIC / QUANT0.3% · 7 holders
TACTICAL / MACRO0.3% · 5 holders
GROWTH / MOMENTUM0.1% · 1 holder
ACTIVIST0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for KRYS in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention KRYS yet.